Randy L. Wei

Randy L. Wei

Auto-generated profile, based on publicly available information

Randy L. Wei

Department of Radiation Oncology, Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA, USA.

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
YCYumay Chen
Yumay Chen
CCChi-Fen Chen
Chi-Fen Chen
HCHuai-Chin Chiang
Huai-Chin Chiang
MPMichelle Pena
Michelle Pena
RPRosaria Polci
Rosaria Polci
DRDaniel Riley
Daniel Riley
NEK1, the first mammalian ortholog of the fungal protein kinase never-in-mitosis A (NIMA), is involved early in the DNA damage sensing/repair pathway. A defect in DNA repair in NEK1-deficient cells is suggested by persistence of DNA double strand breaks after low dose ionizing radiation (IR). NEK1-deficient cells also fail to activate the checkpoint kinases CHK1 and CHK2, and fail to arrest properly at G1/S or G2/M-phase checkpoints after DNA damage.

1 March 2017 in Practical Radiation Oncology
Verified
Journal Article
Closed access
RWRandy L. Wei
Randy L. Wei
MMMalcolm D. Mattes
Malcolm D. Mattes
JYJames Yu
James Yu
ATAdrienne Thrasher
Adrienne Thrasher
HSHui-Kuo Shu
Hui-Kuo Shu
TBTracy Balboni
Tracy Balboni

1 April 2017 in Annals of Palliative Medicine
Verified
Journal Article
Closed access
PDF file
WVWinston Vuong
Winston Vuong
JLJessica Lin
Jessica Lin
RWRandy L. Wei
Randy L. Wei
Palliative radiotherapy (PRT) improves patient quality of life (QoL) through alleviating cancer-associated symptoms such as pain, bleeding, and ulceration. Palliative management of patients with skin malignancies requires consideration of cosmetic and psychosocial outcomes as QoL measures. In this review, we highlight the current literature and advances in the use of PRT for patients with the three most commonly encountered forms of skin malignancies: basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. The disease course and sensitivity to radiation varies, thus dictating the palliative goal and scheduling for PRT.

1 January 2017 in Annals of Palliative Medicine
Verified
Journal Article
Closed access
PDF file
RWRandy L. Wei
Randy L. Wei
CSCharles Simone
Charles Simone
SLStephen Lutz
Stephen Lutz
Society for palliative radiation oncology: report from the Third Annual Meeting (2016)